France 2030 medical device funding is a major public investment opportunity for teams developing implantable medical devices and next-generation surgical robotics. Managed via Bpifrance under the France 2030 investment plan, …
Category:
france
-
-
The HAS / CNEDiMTS route explained science, law, and real-world decisions France operates one of the most structured and evidence-based reimbursement systems for medical devices in Europe. Access is not …
-
franceNews
RIHN 2.0 Reimbursement in France: How to Secure Reimbursement for AI and Genomic Diagnostics
France Redefines Diagnostic Reimbursement with the First AI-Enabled and Genomic Tests Under RIHN 2.0 Introduction France is now setting the pace for evidence-linked reimbursement of diagnostics. Under RIHN 2.0, public …